These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14707260)

  • 21. [New therapeutic approaches in irritable bowel syndrome].
    Müller-Lissner SA
    Z Gastroenterol; 2000 Sep; 38(9):815-6. PubMed ID: 11072681
    [No Abstract]   [Full Text] [Related]  

  • 22. Alosetron (Lotronex) for treatment of irritable bowel syndrome.
    Med Lett Drugs Ther; 2000 Jun; 42(1081):53-4. PubMed ID: 10872030
    [No Abstract]   [Full Text] [Related]  

  • 23. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 24. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 25. Irritable bowel syndrome: an update on treatment options.
    Blackington E
    Adv Nurse Pract; 2000 Oct; 8(10):32-40. PubMed ID: 11761535
    [No Abstract]   [Full Text] [Related]  

  • 26. [The use of Debridat in treating the irritable bowel syndrome].
    Parfenov AI
    Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
    [No Abstract]   [Full Text] [Related]  

  • 27. [Irritable colon].
    Lindberg M
    Ugeskr Laeger; 2001 Oct; 163(41):5694. PubMed ID: 11665483
    [No Abstract]   [Full Text] [Related]  

  • 28. Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.
    Palmer JB
    BMJ; 2003 Jan; 326(7379):51. PubMed ID: 12511473
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotransmitter antagonism in management of irritable bowel syndrome.
    Lembo T
    Lancet; 2000 Mar; 355(9209):1030-1. PubMed ID: 10744083
    [No Abstract]   [Full Text] [Related]  

  • 30. Alosetron for irritable bowel syndrome.
    Barbehenn E; Lurie P; Wolfe SM
    Lancet; 2000 Dec; 356(9246):2009-10. PubMed ID: 11130544
    [No Abstract]   [Full Text] [Related]  

  • 31. So what happened to alosetron?
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2001 May; 32(5):513-4. PubMed ID: 11455947
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy for irritable bowel syndrome.
    Lacy BE
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15031865
    [No Abstract]   [Full Text] [Related]  

  • 33. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
    Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
    Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
    [No Abstract]   [Full Text] [Related]  

  • 34. Irritable bowel syndrome: a practical review.
    Podovei M; Kuo B
    South Med J; 2006 Nov; 99(11):1235-42; quiz 1243-4, 1284. PubMed ID: 17195419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drug for women with irritable bowel syndrome.
    Mayo Clin Health Lett; 2003 Dec; 21(12):4. PubMed ID: 14971349
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonergic modulators in the treatment of irritable bowel syndrome: influence on psychiatric and gastrointestinal symptoms.
    Castle MZ; Silk DB; Libby GW
    Aliment Pharmacol Ther; 2003 Jun; 17(11):1425. PubMed ID: 12786637
    [No Abstract]   [Full Text] [Related]  

  • 37. Tegaserod in patients with irritable bowel syndrome.
    Schooff M; Stelter C
    Am Fam Physician; 2004 Dec; 70(11):2107-8. PubMed ID: 15606056
    [No Abstract]   [Full Text] [Related]  

  • 38. New drug approved for irritable bowel syndrome in women.
    Mayo Clin Womens Healthsource; 2004 Feb; 8(2):3. PubMed ID: 14722489
    [No Abstract]   [Full Text] [Related]  

  • 39. [Functional intestinal disorders and quality of life].
    Chassany O; Bergmann JF
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C54-62. PubMed ID: 11787380
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of irritable bowel syndrome with dicetelium and spasmomen].
    Nedogoda SV; Parshev VV
    Klin Med (Mosk); 2000; 78(10):42-6. PubMed ID: 11220900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.